A centennial review; the 1890 tetanus antitoxin paper of von Behring and Kitasato and the related developments
- PMID: 2046211
- DOI: 10.2302/kjm.40.35
A centennial review; the 1890 tetanus antitoxin paper of von Behring and Kitasato and the related developments
Abstract
The significance of the 1890 tetanus antitoxin paper by von Behring and Kitasato in the development of a new discipline, immunology, is reviewed. The possible reasons why Kitasato lost the first Nobel Prize for medicine to von Behring are presented. These are as follows: (1) The Nobel selection committee literally interpreted Alfred Nobel's will to award the prize to "the person who has made the most important discovery." (2) In the late 19th century, diphtheria was a serious contagious disease which claimed many thousands of lives in the Europe and America; and von Behring's solely authored paper on diphtheria antitoxin clinched the award for him. (3) The merit of tetanus antitoxin to humans, which was the focal point of the 1890 paper on tetanus antitoxin jointly authored by von Behring and Kitasato, was not recognized at the time of the award in 1901; it became apparent only during the First World War.
Similar articles
-
The legacy of von Behring and Kitasato.Immunol Today. 1992 Sep;13(9):374. doi: 10.1016/0167-5699(92)90177-9. Immunol Today. 1992. PMID: 1466755 No abstract available.
-
Behring's discovery of diphtheria and tetanus antitoxins.Immunol Today. 1992 May;13(5):188-90. doi: 10.1016/0167-5699(92)90125-Q. Immunol Today. 1992. PMID: 1642758 No abstract available.
-
Emil von Behring: translational medicine at the dawn of immunology.Nat Rev Immunol. 2017 Jun;17(6):341-343. doi: 10.1038/nri.2017.37. Epub 2017 Apr 10. Nat Rev Immunol. 2017. PMID: 28393925
-
[Better late than never: discovery of MHC restriction awarded with the Nobel Prize after 22 years (Nobel Prize for physiology or medicine in 1996)].Postepy Biochem. 1997;43(2):66-72. Postepy Biochem. 1997. PMID: 9411434 Review. Polish. No abstract available.
-
From the Gorgon's blood to Behring's Blutserumtherapie: A long path towards serum therapy.Immunol Rev. 2024 Nov;328(1):13-23. doi: 10.1111/imr.13391. Epub 2024 Sep 14. Immunol Rev. 2024. PMID: 39276357 Review.
Cited by
-
Chemical inhibitors of the type three secretion system: disarming bacterial pathogens.Antimicrob Agents Chemother. 2012 Nov;56(11):5433-41. doi: 10.1128/AAC.00975-12. Epub 2012 Jul 30. Antimicrob Agents Chemother. 2012. PMID: 22850518 Free PMC article. Review.
-
Transforming vaccinology.Cell. 2024 Sep 19;187(19):5171-5194. doi: 10.1016/j.cell.2024.07.021. Cell. 2024. PMID: 39303685 Review.
-
Research Progress on Small Molecular Inhibitors of the Type 3 Secretion System.Molecules. 2022 Nov 30;27(23):8348. doi: 10.3390/molecules27238348. Molecules. 2022. PMID: 36500441 Free PMC article. Review.
-
B cells: the old new players in reproductive immunology.Front Immunol. 2014 Jun 23;5:285. doi: 10.3389/fimmu.2014.00285. eCollection 2014. Front Immunol. 2014. PMID: 25002862 Free PMC article. Review.
-
Conformation-dependent high-affinity potent ricin-neutralizing monoclonal antibodies.Biomed Res Int. 2013;2013:471346. doi: 10.1155/2013/471346. Epub 2012 Dec 26. Biomed Res Int. 2013. PMID: 23484120 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources